Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

CVS Health Corp. buy Morgan Stanley

Start price
€61.46
15.04.25 / 50%
Target price
-
15.04.26
Performance (%)
10.35%
Price
€67.82
15.12.25
Summary
This prediction is currently active. The prediction currently has a performance of 10.35%. This prediction currently runs until 15.04.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction

CVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.

Performance without dividends (%)
Name 1w 1m
CVS Health Corp. 3.133% 3.133%
iShares Core DAX® 0.795% 1.458%
iShares Nasdaq 100 -3.088% -0.762%
iShares Nikkei 225® -0.952% -2.268%
iShares S&P 500 -1.393% 0.199%

Comments by Morgan_Stanley for this prediction

In the thread CVS Health Corp. diskutieren

CVS Health Co. (NYSE: CVS) had its "overweight" rating re-affirmed by analysts at Morgan Stanley.
Ratings data for CVS provided by MarketBeat

Stopped prediction by Morgan_Stanley for CVS Health Corp.

buy
CVS Health Corp.

Start price
Target price
Perf. (%)
€68.38
14.10.25
€76.91
14.10.26
-0.82%
15.12.25

buy
CVS Health Corp.

Start price
Target price
Perf. (%)
€67.98
03.08.23
€100.41
03.08.24
-20.74%
04.08.24